PCR Column

DOI: 10.4244/EIJ-E-26-00005

Strengthening your cardiovascular care pathway in times of disruption: a practical tool for European hospitals

William Wijns1, MD, PhD; Sandrine Wallace2; on behalf of the RESIL-Card consortium

Cardiovascular disease (CVD) remains the leading cause of death in Europe. Despite major advances in diagnosis and treatment, recent crises − from pandemics to geopolitical instability − have exposed the vulnerability of healthcare systems to disruption. In a global health landscape increasingly shaped by uncertainty, proactive preparedness is no longer optional; it is essential.

To address this challenge, at the initiative of the PCR community, the RESIL-Card project1 supports European cardiovascular professionals in strengthening the resilience of their care pathways. Co-funded by the European Union (EU) under the EU4Health Programme, the initiative has developed and launched a practical, evidence-based tool to help hospitals anticipate disruptions and maintain timely, high-quality cardiovascular care when systems are under pressure.

At the heart of the RESIL-Card tool is a structured self-assessment and improvement framework facilitated by interventional cardiovascular teams. The tool guides users through four steps to evaluate the preparedness of their care pathways across six resilience dimensions that influence care delivery during periods of stress.

Through this collaborative process, multidisciplinary resilience teams – including clinicians, nurses, managers, patients and other stakeholders – map how care is currently organised, identify vulnerabilities and prioritise improvement actions. The result is a visual heatmap highlighting strengths and gaps, supported by practical recommendations and good practice examples identified across Europe.

By using the tool, you can strengthen your capacity to maintain timely diagnosis and treatment for patients with acute and chronic cardiovascular conditions, even during crises. It improves internal coordination, supports strategic planning and helps hospitals align with broader preparedness and resilience objectives at national and European levels.

A distinctive feature of the project is its co-creation approach. Rather than being designed in isolation, the tool was developed in collaboration with stakeholders across the cardiovascular care pathway. Interventional cardiologists, nurses, hospital managers, emergency medical services, public health experts and patient representatives contributed their perspectives to ensure the tool reflects real-world clinical and organisational needs. The underlying methodology has been described in a publication,2 highlighting the value of structural multistakeholder collaboration in designing practical health system solutions.

Importantly, RESIL-Card is not a theoretical exercise. The tool has been tested and validated in real-life clinical environments by interventional teams in several European hospitals. During these pilots, teams assessed its usability and practical value in helping institutions maintain essential cardiovascular services. Their feedback helped refine the tool to ensure both practicality and adaptability across diverse healthcare contexts in Europe.

The RESIL-Card initiative is led by a multidisciplinary consortium coordinated by We CARE,3 PCR’s advocacy group within the non-profit We CARE Alliance, which also hosts the global programmes Stent-Save a Life and SHARE. Together with academic institutions, clinical experts, health system specialists and patient representatives from across Europe, they translated research insights and frontline experience into practical solutions for implementation by cardiovascular teams.

The initiative is also aligned with key European strategic priorities. It supports OECD recommendations on health system resilience and contributes to the objectives of the Safe Hearts Plan, which promotes improved prevention and management of CVD across Europe. It also reinforces the ambitions of the European Union Prevention, Preparedness and Response Plan to strengthen health system resilience against future crises.

As the tool is designed “by and for” the cardiovascular community, interventional cardiologists, nurses, cathlab managers, hospital administrators and multidisciplinary teams all have a role to play in maintaining continuity of care for patients with CVD.

The project has now entered its broad implementation phase, and the consortium is inviting cardiovascular hospitals and professionals across the EU to implement the tool within their institutions.

In doing so, teams will strengthen their own preparedness and demonstrate their commitment to safeguarding cardiovascular care in all circumstances. Ultimately, preparedness is not only about systems or processes − it is about protecting what matters most to us: ensuring that every cardiovascular patient can rely on continuous, high-quality care, even when the unexpected happens.

Volume 22 Number 10
May 15, 2026
Volume 22 Number 10
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al

Original Research

10.4244/EIJ-D-25-01268 Jun 1, 2026
Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry
Tarantini G et al

Research Correspondence

10.4244/EIJ-D-25-01160 Jun 1, 2026
First-in-human experience with a heterotopic cross-caval transcatheter tricuspid valve replacement
Estevez-Loureiro R et al

Original Research

10.4244/EIJ-D-26-00416 May 21, 2026
Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study
Volleberg R et al
Trending articles
87.2

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
34.8

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
20.75

Flashlight

10.4244/EIJ-D-25-01014 Apr 6, 2026
Stent retriever-assisted coronary thrombectomy with continuous aspiration
Liabot Q et al
open access
20

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved